• Achord JL, Gunn CH Jr, Jackson JF. Regional enteritis and HLA concordance in multiple siblings. Dig. Dis. Sci. 27: 330-332 (1982).

• Albini E, Marca G, Mellerio G. Further observations on the in vitro metabolism of chenodeoxycholic acid and ursodeoxycholic acid. Arzneimittelforschung 32: 1554-1557 (1982).

• Andrew E, Hall JG. IgA antibodies in the bile of rats. I. Some characteristics of the primary response. Immunology 45: 169-175 (1982). *

• Angelin B, Bjorkhem I, Einarsson K, Ewerth S. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J. Clin. Invest. 70: 724-731 (1982). *

• Asakura H, Tsuchiya M, Aiso S, Watanabe M, Kobayashi K, Hibi T, Ando K, Takata H, Sekiguchi S. Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis. Gastroenterology 82: 413-418 (1982).

• Ayadi S, Ellouze M, Fredj N, Gargouri M, Hamza H. Primary sclerosing cholangitis. Tunis. Med. 60: 270-274 (1982).

• Azad Khan AK, Truelove SC, Aronson JK. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br. J. Clin. Pharmacol. 13: 523-528 (1982).

• Azria D, Duval G, Brage D, Deltour D, Valette M. Primary sclerosing cholangitis. External biliary drainage by the transhepatic percutaneous approach. A case report. J. Radiol. 63: 359-362 (1982).

• Band PR, Besner JG, Leclaire R, Girard C, Diorio G, Deschamps M, Gelinas M, Larochelle D. Phase I study of 13-cis-retinoic acid toxicity. Cancer Treat. Rep. 66: 1759-1761 (1982).

• Bannaski H. For which liver diseases is immunosuppressive therapy indicated? Med. Klin. [Prax.] 77: 66-71, 74 (1982).

• Bass NM, Burroughs AK, Scheuer PJ, James DG, Sherlock S. Chronic intrahepatic cholestasis due to sarcoidosis. Gut 23: 417-421 (1982). *

• Baur G, Schwalbach G, Tittor W. New aspects of the pathogenesis of primary biliary cirrhosis, a study of 42 patients. Dtsch. Med. Wochenschr. 107: 378-382 (1982).

• Bazzoli F, Fromm H, Sarva RP, Sembrat RF, Ceryak S. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon. Gastroenterology 83: 753-760 (1982).

• Bazzoli F, Roda A, Fromm H, Sarva RP, Roda E, Barbara L. Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey. Dig. Dis. Sci. 27: 417-424 (1982).

• Berg PA, Klein R, Lindenborn-Fotinos J, Kloppel W. ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet 2: 1423-1426 (1982).

• Bernstein RM, Callender ME, Neuberger JM, Hughes GR, Williams R. Anticentromere antibody in primary biliary cirrhosis. Ann. Rheum. Dis. 41: 612-614 (1982). *

• Bhan AK, Dienstag JL, Wands JR, Schlossman SF, Reinherz EL. Alterations of T-cell subsets in primary biliary cirrhosis. Clin. Exp. Immunol. 47: 351-358 (1982). *

• Bikle DD. The vitamin D endocrine system. Adv. Intern. Med. 27: 45-71 (1982).

• Black CM, Welsh KI, Fielder A, Hughes GR, Batchelor JR. HLA antigens and Bf allotypes in SLE: evidence for the association being with specific haplotypes. Tissue Antigens 19: 115-120 (1982).

• Bozian RC, Moussavian SN. Human linolenic acid deficiency. Am. J. Clin. Nutr. 36: 1253-1255 (1982). *

• Brailski Kh, Chernev K, Pomakov P, Bozhianov V. Percutaneous transhepatic cholangiography with an ultra-fine needle (Chiba) in the diagnosis and differential diagnosis of cholestasis. Vutr. Boles. 21: 29-36 (1982).

• Brauman A, Katzir D, Novis B, Eshchar J, Gilboa Y. Primary sclerosing cholangitis. Harefuah. 102: 287-289 (1982).

• Bretagne JF, Tassou R, Ramee MP, Grossetti D, Chevrant-Breton J, Gastard J. Fulminant idiopathic ulcerative colitis, primary sclerosing cholangitis and pyoderma gangrenosum. Gastroenterol. Clin. Biol. 6: 448-453 (1982).

• Brinch L, Teisberg P, Schrumpf E, Akesson I. The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis. Scand. J. Gastroenterol. 17: 523-527 (1982).

• Brooks BJ Jr, Williams WL, Sanders CV, Marier RL. Apparent ketoconazole failure in candidal cholecystitis. Arch. Intern. Med. 142: 1934-1935 (1982).

• Brunner G, Harke U. Treatment of bleeding oesophageal varices. Results of combined medical and endoscopically selective intravascular sclerotherapy. Dtsch. Med. Wochenschr. 107: 1791-1795 (1982).

• Callahan R, Drohan W, Tronick S, Schlom J. Detection and cloning of human DNA sequences related to the mouse mammary tumor virus genome. Proc. Natl. Acad. Sci. U.S.A. 79: 5503-5507 (1982). *

• Carroll BA, Oppenheimer DA. Sclerosing cholangitis: sonographic demonstration of bile duct wall thickening. AJR Am. J. Roentgenol. 139: 1016-1018 (1982). *

• Chen LJ, Kane B 3rd, Bujanover Y, Thaler MM. Development and regulation of bile salt sulfotransferase in rat liver. Biochim. Biophys. Acta 713: 358-364 (1982). *

• Chi YB. Surgical treatment of primary sclerosing cholangitis. Zhonghua Wai Ke Za Zhi 20: 223-226 (1982).

• Clarke DF, George D, Milsap RL, Pogonowska-Wala E, Owerbach J, Lebenthal E, Jusko WJ. Sulfasalazine metabolite pharmacokinetics in pediatric patients with inflammatory bowel disease: effects of disease activity, acetylator phenotype, and age. Pediatr. Pharmacol. (New York) 2: 323-333 (1982).

• Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER. Autoimmune associations in primary biliary cirrhosis. Mayo Clin. Proc. 57: 365-370 (1982).

• Cunnigham D, Mills PR, Quigley EM, Patrick RS, Watkinson G, MacKenzie JF, Russell RI. Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q. J. Med. 51: 162-170 (1982).

• Czaja AJ, Davis GL. Hepatitis non A, non B. Manifestations and implications of acute and chronic disease. Mayo Clin. Proc. 57: 639-652 (1982).

• Danielsson A, Lorentzon R, Larsson SE. Normal hepatic vitamin-D metabolism in icteric primary biliary cirrhosis associated with pronounced vitamin-D deficiency symptoms. Hepatogastroenterology 29: 6-8 (1982).

• Danielsson A, Lorentzon R, Larsson SE. Intestinal absorption and 25-hydroxylation of vitamin D in patients with primary biliary cirrhosis. Scand. J. Gastroenterol. 17: 349-355 (1982).

• Davis GL, Czaja AJ, Baggenstoss AH, Taswell HF. Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis. Mayo Clin. Proc. 57: 303-309 (1982).

• De la Concha EG, Garcia-Rodriguez MC, Zabay JM, Laso MT, Alonso F, Bootello A, Fontan G. Functional assessment of T and B lymphocytes in patients with selective IgM deficiency. Clin. Exp. Immunol. 49: 670-676 (1982). *

• Delacroix DL, Reynaert M, Pauwels S, Geubel AP, Vaerman JP. High serum levels of secretory IgA in liver disease: possible liver origin of the circulating secretory component. Dig. Dis. Sci. 27: 333-340 (1982).

• DeMark BR, Everson GT, Klein PD, Showalter RB, Kern F Jr. A method for the accurate measurement of isotope ratios of chenodeoxycholic and cholic acids in serum. J. Lipid Res. 23: 204-210 (1982). *

• Di Bisceglie AM, Segal I. Terminology of sclerosing cholangitis. J. Clin. Gastroenterol. 4: 480 (1982).

• Dienstag JL, Savarese AM, Cohen RB, Bhan AK. Circulating immune complexes in primary biliary cirrhosis: interactions with lymphoid cells. Clin. Exp. Immunol. 50: 7-16 (1982). *

• Dolle W. Liver damage caused by drugs. Dtsch. Z. Verdau. Stoffwechselkr. 42: 237-244 (1982).

• Doyle FH, Pennock JM, Banks LM, McDonnell MJ, Bydder GM, Steiner RE, Young IR, Clarke GJ, Pasmore T, Gilderdale DJ. Nuclear magnetic resonance imaging of the liver: initial experience. AJR Am. J. Roentgenol. 138: 193-200 (1982). *

• Drozd TN. Differential morphological diagnosis of chronic liver diseases based on the results of puncture biopsy. Arkh. Patol. 44: 73-78 (1982).

• Eason RJ, Croxson MS, Perry MC, Somerfield SD. Addison's disease, adrenal autoantibodies and computerised adrenal tomography. N. Z. Med. J. 95: 569-573 (1982).

• Eggink HF, Houthoff HJ, Huitema S, Gips CH, Poppema S. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Clin. Exp. Immunol. 50: 17-24 (1982). *

• Emerit J, Congy F, Loeper J. Recent data on the epidemiology and etiology of Crohn's disease. Nouv. Presse. Med. 11: 3195-3200 (1982).

• Epstein O, Chapman RW, Lake-Bakaar G, Foo AY, Rosalki SB, Sherlock S. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 83: 1177-1182 (1982).

• Epstein O, Kato Y, Dick R, Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am. J. Clin. Nutr. 36: 426-430 (1982). *

• Everson GT, McKinley C, Lawson M, Johnson M, Kern F Jr. Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology 82: 711-719 (1982).

• Ewerth S. On the enterohepatic circulation of bile acids in man. Acta Chir. Scand. Suppl. 513: 1-38 (1982).

• Falco D, Daniels RA, Conklin R. An unusual case of hypersensitivity vasculitis probably due to allopurinol. J. Med. Soc. N. J. 79: 409-412 (1982).

• Finegold MJ, Carpenter RJ. Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts. Hum. Pathol. 13: 662-665 (1982).

• Fondacaro JD, Heubi JE, Kellogg FW. Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect. Pediatr. Res. 16: 494-498 (1982).

• Freese D, Latimer JS, Gilberstadt S, Kane W, Sharp HL. Sclerosing cholangitis associated with inflammatory bowel disease. Clin. Pediatr. (Phila.) 21: 11-16 (1982).

• Gerba WM, Miller DR, Pahwa S, Cunningham-Rundles C, Gupta S. Chronic granulomatous disease and selective IgA deficiency. Am. J. Pediatr. Hematol. Oncol. 4: 155-160 (1982).

• Gero L, Koranyi L, Szalay F, Buki B, Tamas G Jr. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block. Acta Diabetol. Lat. 19: 55-64 (1982).

• Ghosn PB, Rabbat AG, Trudel J, D'Amico P, Lecours R, Trudel J. Celiac compression syndrome. Can. J. Surg. 25: 377-379 (1982).

• Gibson T, Rodgers V, Potter C, Simmonds HA. Allopurinol treatment and its effect on renal function in gout: a controlled study. Ann. Rheum. Dis. 41: 59-65 (1982). *

• Gill RA, Onstad GR, Cardamone JM, Maneval DC, Sumner HW. Hepatic veno-occlusive disease caused by 6-thioguanine. Ann. Intern. Med. 96: 58-60 (1982).

• Gillberg R, Dotevall G, Ahren C. Chronic inflammatory bowel disease in patients with coeliac disease. Scand. J. Gastroenterol. 17: 491-496 (1982).

• Gilmore IT, Marigold JH, Thompson RP. Half-life time or clearance of indocyanine green in patients with liver disease. Hepatogastroenterology 29: 55-57 (1982).

• Golematis B, Giannopoulos A, Papachristou DN, Dreiling DA. Sclerosing cholangitis of the bifurcation of the common hepatic duct. Mt. Sinai J. Med. 49: 38-40 (1982).

• Gordon HT, Bauernfeind JC. Carotenoids as food colorants. Crit. Rev. Food Sci. Nutr. 18: 59-97 (1982).

• Graham-Brown RA, Sarkany I, Sherlock S. Lichen planus and primary biliary cirrhosis. Br. J. Dermatol. 106: 699-703 (1982).

• Greenberg DA, Hodge SE, Rotter JI. Evidence for recessive and against dominant inheritance at the HLA-"linked" locus in coeliac disease. Am. J. Hum. Genet. 34: 263-277 (1982). *

• Greenberg DA, Lange KL. A maximum likelihood test of the two locus model for coeliac disease. Am. J. Med. Genet. 12: 75-82 (1982).

• Gupta RC, Dickson ER, McDuffie FC, Baggenstoss AH. Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features. Am. J. Med. 73: 192-198 (1982).

• Gurian LE, Keeffe EB. Pancreatic insufficiency associated with ulcerative colitis and pericholangitis. Gastroenterology 82: 581-585 (1982).

• Handelsman B, Bonorris G, Marks JW, Schoenfield LJ. Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters. Am. J. Physiol. 243: G424-G427 (1982).

• Heikkinen J, Maentausta O, Ylostalo P, Janne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur. J. Obstet. Gynecol. Reprod. Biol. 14: 153-162 (1982).

• Hendricks AA, Hutcheon DF, Maddrey WC, Farmer ER, Provost TT. Cutaneous immunoglobulin deposition in primary biliary cirrhosis. Arch. Dermatol. 118: 634-637 (1982).

• Herlong HF, Recker RR, Maddrey WC. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology 83: 103-108 (1982).

• Hill DL, Grubbs CJ. Retinoids as chemopreventive and anticancer agents intact animals (review). Anticancer Res. 2: 111-124 (1982).

• Hirata Y. Insulin autoimmune syndrome. Nippon Rinsho 40: 387-391 (1982).

• Hishon S, Tobin G, Ciclitira PJ. A clinical trial of levamisole in primary biliary cirrhosis. Postgrad. Med. J. 58: 701-703 (1982). *

• Hislop WS, Hopwood D, Bouchier IA. Primary biliary cirrhosis in elderly females. Age Ageing 11: 153-159 (1982).

• Hislop WS, Masterton N, Bouchier IA, Hopwood D. Cirrhosis and primary liver cell carcinoma in Tayside: a five year study. Scott. Med. J. 27: 29-36 (1982).

• Hodes JE, Grosfeld JL, Weber TR, Schreiner RL, Fitzgerald JF, Mirkin LD. Hepatic failure in infants on total parenteral nutrition (TPN): clinical and histopathologic observations. J. Pediatr. Surg. 17: 463-468 (1982).

• Hoek FJ, Grijm R, Sanders GT, Tytgat GN, Wilmink JM. Removal of bile acids from the blood by hemodialysis with a polyacrylonitril membrane: treatment of pruritus of cholestatic disease. Digestion 23: 135-140 (1982).

• Holda ME, Ryan JR. Hepatobiliary rickets. J. Pediatr. Orthop. 2: 285-287 (1982).

• Holdstock G, Chastenay BF, Krawitt EL. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity. Gastroenterology 82: 206-212 (1982).

• Holland EJ, Loren AB, O'Donnell MJ, Spence DJ, Tessler HH, Yokoyama MM. HLA-B27, Klebsiella pneumoniae, and the relation to acute anterior uveitis. Invest. Ophthalmol. Vis. Sci. 22: 213-219 (1982). *

• Honeybourne D, Dyer PA, Mohr PD. Familial myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 45: 854-856 (1982).

• Humbert W, Aprahamian M, Stock C, Grenier JF. Copper accumulation in primary biliary cirrhosis. An electron and X-ray microanalytical study. Histochemistry 74: 85-93 (1982).

• Husby G, Blomhoff JP, Elgjo K, Williams RC Jr. Immunohistochemical characterization of hepatic tissue lymphocyte subpopulations in liver disease. Scand. J. Gastroenterol. 17: 855-860 (1982).

• Isaacson P. Immunoperoxidase study of the secretory immunoglobulin system in colonic neoplasia. J. Clin. Pathol. 35: 14-25 (1982). *

• Iwamura K. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones. Tokai. J. Exp. Clin. Med. 7: 671-683 (1982).

• Janossy G, Montano L, Selby WS, Duke O, Panayi G, Lampert I, Thomas JA, Granger S, Bofill M, Tidman N, Thomas HC, Goldstein G. T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host disease. J. Clin. Immunol. 2: 42S-56S (1982).

• Jernigan JD, Harbison RD. Role of biotransformation in the potentiation of halocarbon hepatotoxicity by 2,5-hexanedione. J. Toxicol. Environ. Health 9: 761-781 (1982).

• Jorge A, Fay O, Palazzi J, Sanchez D, Tanno H, Diaz M. Determination of cholic and sulfolithocholic acids in various hepatopathies. Acta Gastroenterol. Latinoam. 12: 143-147 (1982).

• Kanazawa Y, Koizumi M, Hirakawa H, Endo K, Yoshida S, Miyakawa T, Konno Y, Goto Y, Goto J, Nambara T. The effect of ursodeoxycholic acid on biliary bile acid composition in patients with cholesterol gallstone. Tohoku. J. Exp. Med. 136: 235-249 (1982). *

• Karr RW, Hahn Y, Schwartz BD. Structural identity of human histocompatibility leukocyte antigen-B27 molecules from patients with ankylosing spondylitis and normal individuals. J. Clin. Invest. 69: 443-450 (1982). *

• Kato Y, Epstein O, Dick R, Sherlock S. Radiological patterns of cortical bone modelling in women with chronic liver disease. Clin. Radiol. 33: 313-317 (1982).

• Kato Y, Kumagai M, Kobayashi K, Hattori N, Sasazuki T. Histocompatibility antigens in primary biliary cirrhosis. Am. J. Gastroenterol. 77: 312-313 (1982).

• Kennedy HJ, Callender ST, Truelove SC, Warner GT. Haematological aspects of life with an ileostomy. Br. J. Haematol. 52: 445-454 (1982).

• Kern F Jr, Everson GT, DeMark B, McKinley C, Showalter R, Braverman DZ, Szczepanik-Van Leeuwen P, Klein PD. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids. J. Lab. Clin. Med. 99: 798-805 (1982).

• Kesaniemi YA, Salaspuro MP, Vuoristo M, Miettinen TA. Biliary lipid secretion in chronic cholestatic liver disease. Gut 23: 931-938 (1982). *

• Kinyoun JL. Treatment of Candida endophthalmitis. Retina 2: 215-222 (1982).

• Kivilaakso E. Antacids and bile salts. Scand. J. Gastroenterol. Suppl. 75: 16-19 (1982).

• Kloppel G, Kirchhof M, Berg PA. Natural course of primary biliary cirrhosis. I. A morphological, clinical and serological analysis of 103 cases. Liver 2: 141-151 (1982).

• Kobyliansky E, Micle S, Goldschmidt-Nathan M, Arensburg B, Nathan H. Jewish populations of the world: genetic likeness and differences. Ann. Hum. Biol. 9: 1-34 (1982).

• Krell H, Hoke H, Pfaff E. Development of intrahepatic cholestasis by alpha-naphthylisothiocyanate in rats. Gastroenterology 82: 507-514 (1982).

• Kurtz W, Leuschner U, Hellstern A, Janka P. Sex differences in rat liver bile acids. Hepatogastroenterology 29: 227-231 (1982).

• Lazarow PB, Shio H, Leroy-Houyet MA. Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat. J. Lipid Res. 23: 317-326 (1982). *

• Lee WM, Silva F, Price JB Jr. Gastrin-secreting tumor of the duodenum (G-cell apudoma) associated with secondary biliary cirrhosis. Cancer 49: 2596-2601 (1982).

• Lefkowitch JH. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and "cholangitis lenta". Hum. Pathol. 13: 19-24 (1982).

• Lefkowitch JH. Primary sclerosing cholangitis. Arch. Intern. Med. 142: 1157-1160 (1982).

• Leistner K, Wessel G. Epidemiologic aspects of seronegative spondylarthritis. Z. Gesamte. Inn. Med. 37: 627-632 (1982).

• Leuschner U, Strohm WD, Classen M. Clinical features of inflammatory bowel disease. Acta Med. Austriaca. 9: 9-17 (1982).

• Liehr H. Endotoxins and the pathogenesis of hepatic and gastrointestinal diseases. Ergeb. Inn. Med. Kinderheilkd. 48: 117-193 (1982).

• Lindenborn-Fotinos J, Sayers TJ, Berg PA. Mitochondrial antibodies in primary biliary cirrhosis. VI. Association of the complement fixing antigen with a component of the mitochondrial F1-ATPase complex. Clin. Exp. Immunol. 50: 267-274 (1982). *

• Lindgren S, Eriksson S. IgM in primary biliary cirrhosis. Physicochemical and complement activating properties. J. Lab. Clin. Med. 99: 636-645 (1982).

• Linnet K, Kelbaek H. The patterns of glycine and taurine conjugates of bile acids in serum in hepatobiliary disease. Scand. J. Gastroenterol. 17: 919-924 (1982).

• Longstreth GF, Green R. Folate levels in inflammatory bowel disease. N. Engl. J. Med. 306: 1488 (1982).

• MacDonald JR, Gandolfi AJ, Sipes IG. Covalent binding of 14C-1,1,2-trichloroethane to hepatic proteins following acetone pretreatment. Drug Chem. Toxicol. 5: 233-247 (1982).

• MacDonald JR, Gandolfi AJ, Sipes IG. Acetone potentiation of 1,1,2-trichloroethane hepatotoxicity. Toxicol. Lett. 13: 57-69 (1982).

• Madigand M, Oger JJ, Fauchet R, Sabouraud O, Genetet B. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. J. Neurol. Sci. 53: 519-529 (1982).

• Maier K, Fischer C, Klotz U, Heinkel K. 5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl.). Dtsch. Med. Wochenschr. 107: 1131-1134 (1982).

• Manifold IH, Bishop FM, Cloke P, Triger DR, Underwood JC. Lysozyme in chronic liver disease: a biochemical and histological study. J. Clin. Pathol. 35: 815-819 (1982). *

• Manns M, Meyer zum Buschenfelde KH. A mitochondrial antigen-antibody system in cholestatic liver disease detected by radioimmunoassay. Hepatology 2: 1-7 (1982).

• Marigold JH, Bull HJ, Gilmore IT, Coltart DJ, Thompson RP. Direct measurement of hepatic extraction of chenodeoxycholic acid and ursodeoxycholic acid in man. Clin. Sci. (Lond.) 63: 197-203 (1982).

• Matloff DS, Alpert E, Resnick RH, Kaplan MM. A prospective trial of D-penicillamine in primary biliary cirrhosis. N. Engl. J. Med. 306: 319-326 (1982).

• Matloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HJ. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology 83: 97-102 (1982).

• Mayberry JF, Dew MJ, Morris JS. Monozygotic twins with ulcerative colitis. Postgrad. Med. J. 58: 112-114 (1982). *

• McLean GK, Ring EJ, Freiman DB. Therapeutic alternatives in the treatment of intrahepatic biliary obstruction. Radiology 145: 289-295 (1982). *

• Meek FL. A direct binding assay for mitochondrial autoantibodies. J. Immunol. Methods 51: 109-118 (1982).

• Meredith TJ, Williams GV, Maton PN, Murphy GM, Saxton HM, Dowling RH. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones. Gut 23: 382-389 (1982). *

• Meryhew NL, Marsden K, Runquist OA. The quantitative relationship between clearance rate constants and number of C1-fixing sites. J. Immunol. 129: 1147-1152 (1982).

• Mills PR, Boyle P, Quigley EM, Birnie GG, Jarrett F, Watkinson G, MacSween RN. Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J. Clin. Pathol. 35: 541-543 (1982). *

• Minami Y, Seki K, Nishikawa M, Kawata S, Miyoshi S, Imai Y, Tarui S, Kakiuchi Y, Shinji Y, Kiyonaga G. Laparoscopic findings of the liver in the diagnosis of primary biliary cirrhosis: "reddish patch", a laparoscopic feature in the asymptomatic stage. Endoscopy 14: 203-208 (1982).

• Miyai K, Javitt NB, Gochman N, Jones HM, Baker D. Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid. Lab. Invest. 46: 428-437 (1982).

• Molden D, Abraham JL. Pulmonary hypertension. Its association with hepatic cirrhosis and iron accumulation. Arch. Pathol. Lab. Med. 106: 328-331 (1982).

• Moller P, Vinje O, Berg K. HLA antigens, psoriasis and acute anterior uveitis in Bechterew's syndrome (ankylosing spondylitis). Clin. Genet. 21: 215-221 (1982).

• Morgan MY, Marshall AW, Milsom JP, Sherlock S. Plasma amino-acid patterns in liver disease. Gut 23: 362-370 (1982). *

• Moss DW. Alkaline phosphatase isoenzymes. Clin. Chem. 28: 2007-2016 (1982).

• Mozdzen JJ Jr, Keren DF. Detection of immunoglobulin A by immunofluorescence in glycol methacrylate-embedded human colon. J. Histochem. Cytochem. 30: 532-535 (1982). *

• Mueller PR, vanSonnenberg E, Simeone JF. Fine-needle transhepatic cholangiography. Indications and usefulness. Ann. Intern. Med. 97: 567-572 (1982).

• Munoz LE, De Villiers D, Markham D, Whaley K, Thomas HC. Complement activation in chronic liver disease. Clin. Exp. Immunol. 47: 548-554 (1982). *

• Muting D, Fischer R, Kalk JF, Kruck P. Chronic destructive non-suppurating cholangitis. Fortschr. Med. 100: 1179-1187 (1982).

• Nakanuma Y, Kono N, Ohta G, Kato Y, Kobayashi K. Ultrastructural changes of bile duct epithelium in primary biliary cirrhosis in relation to progression of bile duct loss. Virchows Arch. A. Pathol. Anat. Histopathol. 398: 149-161 (1982).

• Nakanuma Y, Ohta G, Kobayashi K, Kato Y. Histological and histometric examination of the intrahepatic portal vein branches in primary biliary cirrhosis without regenerative nodules. Am. J. Gastroenterol. 77: 405-413 (1982).

• Nelson RA. Use and misuse of vitamins in the elderly. Geriatrics 37: 138-140, 144 (1982).

• Neuberger J, Portmann B, Macdougall BR, Calne RY, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N. Engl. J. Med. 306: 1-4 (1982).

• Nguyen GK. Primary extranodal non-Hodgkin's lymphoma of the extrahepatic bile ducts. Report of a case. Cancer 50: 2218-2222 (1982).

• Nishida T, Miwa H, Yamamoto M, Koga T, Yao T. Bile acid absorption kinetics in Crohn's disease on elemental diet after oral administration of a stable-isotope tracer with chenodeoxycholic-11, 12-d2 acid. Gut 23: 751-757 (1982). *

• Novikova AV, Shcherbakov IT, Ol'shanskii IaO, Iurkov MM, Levitan MKh. Features of inflammation of the mucosa of the large intestine in nonspecific ulcerative colitis and Crohn's disease. Arkh. Patol. 44: 31-39 (1982).

• Oen K, Petty RE, Schroeder ML. Immunoglobulin A deficiency: genetic studies. Tissue Antigens 19: 174-182 (1982).

• Oku T, Akamatsu A, Hosoya N. Property and physiological role of biliary secretory IgA in rats. J. Nutr. Sci. Vitaminol. (Tokyo) 28: 643-653 (1982).

• Pelletier G, Briantais MJ, Buffet C, Pillot J, Etienne JP. Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver. Gut 23: 475-480 (1982). *

• Peppard JV, Orlans E, Andrew E, Payne AW. Elimination into bile of circulating antigen by endogenous IgA antibody in rats. Immunology 45: 467-472 (1982). *

• Peters M, Tinberg HM, Govindarajan S. Immunocytochemical identity of hepatocellular hyalin in alcoholic and non-alcoholic liver diseases. Liver 2: 361-368 (1982).

• Pitt HA, Thompson HH, Tompkins RK, Longmire WP Jr. Primary sclerosing cholangitis: results of an aggressive surgical approach. Ann. Surg. 196: 259-268 (1982). *

• Podda M, Zuin M, Carulli N, Ponz de Leon M, Dioguardi ML. Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses. J. Int. Med. Res. 10: 59-63 (1982).

• Pond SM. Effects on the liver of chemicals encountered in the workplace. West J. Med. 137: 506-514 (1982). *

• Popov MS, Rutkovskii OV. Primary biliary liver cirrhosis with a granulomatous reaction. Arkh. Patol. 44: 60-63 (1982).

• Radzevich IM. Two forms of alkaline phosphatase in blood serum in liver diseases. Ukr. Biokhim. Zh. 54: 525-529 (1982).

• Rajagopalan N, Lindenbaum S. The binding of Ca2+ to taurine and glycine-conjugated bile salt micelles. Biochim. Biophys. Acta 711: 66-74 (1982).

• Ramarli D, Canonica GW, Melioli G, Biagioni P, Nieri S, Casini A, Surrenti C. Abnormalities of immunocompetent cells in primary biliary cirrhosis. Scand. J. Immunol. 16: 201-207 (1982).

• Rammohan KW, McFarland HF, McFarlin DE. Subacute sclerosing panencephalitis after passive immunization and natural measles infection: role of antibody in persistence of measles virus. Neurology 32: 390-394 (1982).

• Ramond MJ, Nouel O, Degott C, Lebrec D, Benhamou JP. Allopurinol-induced hepatitis. Report of a case and review of the literature. Gastroenterol. Clin. Biol. 6: 138-142 (1982).

• Rhodes JM, Potter BJ, Brown DJ, Jewell DP. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. Gastroenterology 82: 1327-1334 (1982).

• Ritland S, Skrede S, Johansen O. A long-term follow-up study of the hepatic copper and serum ceruloplasmin concentrations in patients with chronic liver disease. Scand. J. Gastroenterol. 17: 545-551 (1982).

• Roda E, Bazzoli F, Labate AM, Mazzella G, Roda A, Sama C, Festi D, Aldini R, Taroni F, Barbara L. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology 2: 804-810 (1982).

• Rosner IA, Richter DE, Huettner TL, Kuffner GH, Wisnieski JJ, Burg CG. Spondyloarthropathy associated with hidradenitis suppurative and acne conglobata. Ann. Intern. Med. 97: 520-525 (1982).

• Rouffet F, Fingerhut A, Desoutter P, Blanc P. Primary sclerosing cholangitis associated with ulcerohemorrhagic rectocolitis. Review of the literature apropos of a case disclosed by a rare manifestation: biliary peritonitis. J. Chir. (Paris) 119: 577-582 (1982).

• Roy CC, Weber AM, Morin CL, Lepage G, Brisson G, Yousef I, Lasalle R. Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts. J. Pediatr. Gastroenterol. Nutr. 1: 469-478 (1982).

• Ruppin DC, Frydman MI, Lunzer MR. Value of serum gamma-glutamyltransferase activity in the diagnosis of hepatobiliary disease. Med. J. Aust. 1: 421-424 (1982).

• Rutgeerts P, Ghoos Y, Vantrappen G. Kinetics of primary bile acids in patients with non-operated Crohn's disease. Eur. J. Clin. Invest. 12: 135-143 (1982).

• Saito K, Matsumoto S, Yokoyama T, Okaniwa M, Kamoshita S. Pathology of chronic vitamin E deficiency in fatal familial intrahepatic cholestasis (Byler disease). Virchows Arch. A. Pathol. Anat. Histol. 396: 319-330 (1982).

• Sakurami T, Ueno Y, Iwaki Y, Park MS, Terasaki PI, Saji H. HLA-DR specificities among Japanese with several autoimmune diseases. Tissue Antigens 19: 129-133 (1982).

• Samuelson K, Aly A, Johansson C, Norman A. Serum and urinary bile acids in patients with primary biliary cirrhosis. Scand. J. Gastroenterol. 17: 121-128 (1982).

• Schlaeger R, Haux P, Kattermann R. Studies on the mechanism of the increase in serum alkaline phosphatase activity in cholestasis: significance of the hepatic bile acid concentration for the leakage of alkaline phosphatase from rat liver. Enzyme 28: 3-13 (1982).

• Schrumpf E, Fausa O, Forre O, Dobloug JH, Ritland S, Thorsby E. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand. J. Gastroenterol. 17: 187-191 (1982).

• Schrumpf E, Fausa O, Kolmannskog F, Elgjo K, Ritland S, Gjone E. Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand. J. Gastroenterol. 17: 33-39 (1982).

• Schuurman HJ, Vogten AJ, Schalm SW, Fevery J. Clinical evaluation of the liver cell membrane autoantibody assay. Digestion 23: 184-193 (1982).

• Selinger MJ, Matloff DS, Kaplan MM. gamma-Glutamyl transpeptidase activity in liver disease: serum elevation is independent of hepatic GGTP activity. Clin. Chim. Acta 125: 283-290 (1982).

• Senati E, Marconi F, Tomassini N, Stipa F. Papillomatosis of the bile ducts: a clinical case. Chir. Ital. 34: 432-437 (1982).

• Sepersky R, Callow A, Kanel G, Kaplan M. Portasystemic shunts in primary biliary cirrhosis: survival is the same as in patients with Laennec's cirrhosis and postnecrotic cirrhosis. Dig. Dis. Sci. 27: 507-512 (1982).

• Sherlock S. Patterns of hepatocyte injury in man. Lancet 1: 782-786 (1982).

• Sherlock S. Primary biliary cirrhosis: critical evaluation and treatment policies. Scand. J. Gastroenterol. Suppl. 77: 63-74 (1982).

• Shimomura H. Studies on anti-LP-1 and anti-Tamm-Horsfall glycoprotein in chronic liver disease using ADCC assay against antigen-coated target cells. Acta Med. Okayama 36: 361-370 (1982).

• Shore A, Ansell BM. Juvenile psoriatic arthritis - an analysis of 60 cases. J. Pediatr. 100: 529-535 (1982).

• Simko V, Kelley RE, Dincsoy HP, Gimmon Z, Willmann K. Exercise in rats with liver injury induced by carbon tetrachloride or bile duct obstruction. Blood cholic acid and liver histology. Res. Exp. Med. (Berl.) 181: 135-145 (1982).

• Simon FR, Reichen J. Bile secretory failure: recent concepts of the pathogenesis of intrahepatic cholestasis. Prog. Liver Dis. 7: 195-206 (1982).

• Skrede S, Solberg HE, Ritland S, Blomhoff JP, Schrumpf E, Elgjo K, Gjone E. Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease. Clin. Chem. 28: 1177-1181 (1982).

• Sloan RW. Hyperuricemia and gout. J. Fam. Pract. 14: 923-926, 930-931, 934 (1982).

• Smevik B, Ritland S, Nilsen T, Johansen O. Liver attenuation values at computed tomography related to liver copper content. Scand. J. Gastroenterol. 17: 461-463 (1982).

• Smolen JS, Gangl A, Polterauer P, Menzel EJ, Mayr WR. HLA antigens in inflammatory bowel disease. Gastroenterology 82: 34-38 (1982).

• Solomons NW. Giardiasis: nutritional implications. Rev. Infect. Dis. 4: 859-869 (1982).

• Spivak W, Grand RJ, Eraklis A. A case of primary sclerosing cholangitis in childhood. Gastroenterology 82: 129-132 (1982).

• Spooner RJ, Smith DH, Bedford D, Beck PR. Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis. J. Clin. Pathol. 35: 638-641 (1982). *

• Summers RW, Harker L. Ulcerative colitis and sensorineural hearing loss: is there a relationship? J. Clin. Gastroenterol. 4: 251-252 (1982).

• Sutherland JD, Macdonald IA, Forrest TP. The enzymic and chemical synthesis of ursodeoxycholic and chenodeoxycholic acid from cholic acid. Prep. Biochem. 12: 307-321 (1982).

• Taal BG, Schalm SW, de Bruyn AM, Kornman-vd Bosch HJ. Monomeric (7S) IgM in primary biliary cirrhosis. Scand. J. Gastroenterol. 17: 173-175 (1982).

• Takikawa H, Otsuka H, Beppu T, Seyama Y, Yamakawa T. Quantitative determination of bile acid glucuronides in serum by mass fragmentography. J. Biochem. 92: 985-998 (1982).

• Tanggo Y, Fujiyama S, Kin F, Tashiro A, Shiraoku H, Akahoshi M, Sato Y, Hashiguchi O, Sagara K. Clinical usefulness of serum cholylglycine determination in various liver diseases. Gastroenterol. Jpn. 17: 447-452 (1982).

• Thistle JL, LaRusso NF, Hofmann AF, Turcotte J, Carlson GL, Ott BJ. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study. Dig. Dis. Sci. 27: 161-168 (1982).

• Thomas HC, Brown D, Labrooy J, Epstein O. T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment. J. Clin. Immunol. 2: 57S-60S (1982).

• Thompson HH, Pitt HA, Tompkins RK, Longmire WP Jr. Primary sclerosing cholangitis: a heterogenous disease. Ann. Surg. 196: 127-136 (1982). *

• Tint GS, Salen G, Colalillo A, Graber D, Verga D, Speck J, Shefer S. Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones. Ann. Intern. Med. 97: 351-356 (1982).

• Tison V, Callea F, Morisi C, Mancini AM, Desmet VJ. Spontaneous "primary biliary cirrhosis" in rabbits. Liver 2: 152-161 (1982).

• Tobe K. Electron microscopy of liver lesions in primary biliary cirrhosis. II. A bile duct with chronic non-suppurative destructive cholangitis. Acta Pathol. Jpn. 32: 345-357 (1982).

• Tobe K. Electron microscopy of liver lesions in primary biliary cirrhosis. I. Intrahepatic bile duct oncocytes. Acta Pathol. Jpn. 32: 57-70 (1982).

• Tobias R, Sapire KE, Coetzee T, Marks IN. Male infertility due to sulphasalazine. Postgrad. Med. J. 58: 102-103 (1982). *

• Tonami N, Nakajima K, Hisada K, Tanaka N, Kobayashi K. A noninvasive method for evaluating portal circulation by administration of Ti-201 per rectum. J. Nucl. Med. 23: 965-972 (1982).

• Trautmann F, Arnold W, Manns M, Stoltenburg-Didinger G, Meyer zum Buschenfelde KH. Antimitochondrial antibodies against the M2-antigen with immune vasculitis and discoid lupus erythematosus without proof of liver disease. Z. Gastroenterol. 20: 659-666 (1982).

• Triger DR, Charlton CA, Ward AM. What does the antimitochondrial antibody mean? Gut 23: 814-818 (1982). *

• Uflacker R, Wholey MH, Amaral NM, Lima S. Parasitic and mycotic causes of biliary obstruction. Gastrointest. Radiol. 7: 173-179 (1982).

• Uibo RM, Helin HJ, Krohn KJ. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits. Clin. Exp. Immunol. 48: 505-512 (1982). *

• Ulfarsson J, Gudmundsson S, Birgisdottir B, Kjeld JM, Jensson O. Selective serum IgA deficiency in Icelanders. Frequency, family studies and Ig levels. Acta Med. Scand. 211: 481-487 (1982).

• Valla D, Delage Y, Habibi B, Sonsino E, Darnis F, Bodin F. Ulcerative colitis and primary immunoglobulin deficiency. Gastroenterol. Clin. Biol. 6: 879-885 (1982).

• van der Hoek EW, Yap SH, Lamers CB, van Tongeren JH, Strijk S, Boetes C, van Haelst UJ. Sclerosing cholangitis, a variable disease picture. Ned. Tijdschr. Geneeskd. 126: 1724-1729 (1982).

• van Hees PA, van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J. Clin. Gastroenterol. 4: 333-336 (1982).

• Vasey FB, Espinoza LR, Bocanegra TS, Germain BF. The major histocompatibility complex. Ann. Clin. Lab. Sci. 12: 16-22 (1982).

• Vender RJ, Spiro HM. Inflammatory bowel disease and pregnancy. J. Clin. Gastroenterol. 4: 231-249 (1982).

• Vilstrup H, Bucher D, Krog B, Damgard SE. Elimination of infused amino acids from plasma of control subjects and of patients with cirrhosis of the liver. Eur. J. Clin. Invest. 12: 197-202 (1982).

• Volmer J. The effectivity of immunosuppressive therapy on chronic aggressive (active) hepatitis and on chronic nonsuppurative destructive cholangitis (PBC). Morphometric investigations on the portal tracts of the liver. Liver 2: 82-94 (1982).

• Weemaes C, van Munster P, Bakkeren J. Immunological studies in two children of a mother with IgA deficiency and anti-IgA antibodies. Clin. Immunol. Immunopathol. 23: 145-151 (1982).

• Whelan G, Peters M, Desmond PV, Bhathal PS. Alcohol unrelated hepato-biliary disorders in the alcoholic: the role of liver biopsy in determining the aetiology of liver disease. Aust. N. Z. J. Med. 12: 34-38 (1982).

• Witzleben CL. Bile duct paucity ("intrahepatic atresia"). Perspect. Pediatr. Pathol. 7: 185-201 (1982).

• Wurm K. Current status of clinical and scientific sarcoidosis research 100 years later. Fortschr. Med. 100: 1560-1563 (1982).

• Yamaguchi Y, Yamaguchi K, Babb JL, Gans H. In vivo quantitation of the rat liver's ability to eliminate endotoxin from portal vein blood. J. Reticuloendothel. Soc. 32: 409-422 (1982).

• Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br. J. Dermatol. 106: 323-330 (1982).

• Zile MH, Inhorn RC, DeLuca HF. Metabolites of all-trans-retinoic acid in bile: identification of all-trans- and 13-cis-retinoyl glucuronides. J. Biol. Chem. 257: 3537-3543 (1982). *

• Zouboulis-Vafiadis I, Dumont M, Erlinger S. Conjugation is rate limiting in hepatic transport of ursodeoxycholate in the rat. Am. J. Physiol. 243: G208-G213 (1982).

Number of references = 227

www psc-literature.org